|
Nature Publishing Group and BioCentury Launch Site License Model and HTML Format for SciBX(TM)
(Marketwire Via Acquire Media NewsEdge) LONDON and REDWOOD CITY, CA, November 10 / MARKET WIRE/ --
Nature Publishing Group and
BioCentury Publications, Inc. today announce the launch of a full-text HTML
version of SciBX: Science Business eXchange to complement the existing
distribution via PDF. The new format supports institutional purchasers
keen to provide site-wide access for their users via www.nature.com/scibx.
Published weekly, SciBX provides concise analysis of the scientific content
and commercial potential of the most important translational research with
the potential to transform human therapeutics and diagnostics. By
distilling the flood of life sciences literature down to the 25 key
scientific developments each week and providing in-depth analysis of the
most important findings, SciBX provides a unique scientific and commercial
perspective on today's breakthrough science. The same content will be
published weekly in both formats.
The HTML version is expected to appeal to librarians serving academic and
corporate research institutions.
Peter Collins, Publishing Director at Nature Publishing Group, said: "This
is a valuable development for SciBX. SciBX is now compatible with the site
license subscription model that many of our customers are familiar with,
whilst maintaining the simplicity and convenience of PDF delivery for
biotechnology and pharmaceutical executives and the investment community."
Under the site license option, SciBX will be integrated with the services
on www.nature.com, allowing full-text search of archived content,
registration for Table of Contents E-alerts, links to references and
inclusion of articles from SciBX in Saved Search results. The complete
archive back to Issue 1 will be available in HTML by the end of the year.
Pricing for site-wide access is calculated based on institution type and
size.
David Flores, Co-Founder, President and CEO of BioCentury noted that SciBX
plays a key role in communicating between academic and corporate
scientists: "SciBX serves academic researchers and their institutions by
showcasing the value of their intellectual property and identifying the
critical next steps that industry believes are necessary to bring their
innovative science to the healthcare community. So, SciBX is a unique
literature awareness and educational tool for academic scientists. And for
the corporate R&D and business development departments, SciBX is an
essential awareness and analysis tool that identifies new science with
potential commercial, competitive and investment impact."
About SciBX
SciBX: Science-Business eXchange is a joint publication from BioCentury
Publications, Inc. and Nature Publishing Group that evaluates hundreds of
high impact peer-reviewed scientific papers and selects the most
commercially relevant findings that merit deeper analysis. Each issue
contains Analysis, in-depth articles examining the commercial impact and
next steps required to translate the newest developments in the lab into
innovative healthcare solutions. This coverage is complemented by The
Distillery, a compilation of the most recently published science with
commercial implications, including information on patent and licensing
status. SciBX is published weekly in PDF format and is e-mailed to personal
subscribers throughout the world. SciBX is also now available as a
full-text, HTML web site for institutional site-wide access at
www.nature.com/scibx.
About BioCentury
BioCentury Publications, Inc., independently owned and based in Redwood
City, Calif., provides essential biopharma intelligence from offices in the
U.S. and Europe. Over nearly 16 years, a global audience of biotech and
pharmaceutical executives and investors has benefited from BioCentury's
deep knowledge, data-driven analysis, independent perspective and
trustworthy content available through the company's publications, online
data resources and collaborative industry conferences. Long respected for
the thought leadership provided by BioCentury, the Bernstein Report on
BioBusiness?, the company also publishes BioCentury Extra, a concise
daily news report for executives, and BioCentury Part II, a complete weekly
compendium of deals, product developments and financing events. These
authoritative reports are backed by the BCIQ(TM) online business
intelligence platform, which provides access to information on more than
4,000 public and private companies, 5,000 biopharma compounds and $200
billion in financings. For more information, please visit
www.biocentury.com.
About Nature Publishing Group
Nature Publishing Group (NPG) is dedicated to serving the academic,
professional scientific and medical communities. NPG's flagship title,
Nature, was first published in 1869. NPG also publishes Nature
Biotechnology and Nature Reviews Drug Discovery -- the
pre-eminent publications for academic and corporate scientists interested
in drug discovery -- together with the Nature research journals, Nature
Reviews, Nature Clinical Practice and a range of prestigious academic
journals including society-owned publications. NPG also provides news
content through Nature News and scientific career information and free job
postings on Naturejobs. NPG is a global company with principal offices in
London and New York and offices in Basingstoke, Boston, Buenos Aires,
Delhi, Hong Kong, Madrid, Melbourne, Munich, Paris, San Francisco, Tokyo
and Washington DC. For more information, please go to www.nature.com.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Media Inquiries Contact:
Thomas Carey
BioCentury Publications, Inc.Email Contact
+1 650 595-5333
BioCentury Publications, Inc.
P.O. Box 1246
San Carlos, CA 94070, USAwww.biocentury.com
Grace Baynes
Nature Publishing GroupEmail Contact
+44 (0)20 7014 4063
Nature Publishing Group
75 Varick Street
New York, NY 10013, USAwww.nature.com
Copyright ? 2008 Marketwire
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
Activate Email 
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.
